Primary Mediastinal Large B-Cell Lymphoma Refractory Clinical Trials in Taipei

A Study to Evaluate the Safety and Clinical Activity of GF- CART01 (CD20/19 CAR T Cell) in Subjects With Relapsed or Refractory B-Cell Hematological Malignancies